Angelalign Technology (HKSE:06699) 3-Year EBITDA Growth Rate : -14.60% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Angelalign Technology 3-Year EBITDA Growth Rate?

Angelalign Technology's EBITDA per Share for the six months ended in Dec. 2023 was HK$0.21.

During the past 12 months, Angelalign Technology's average EBITDA Per Share Growth Rate was -52.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -14.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 17.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Angelalign Technology was 63.00% per year. The lowest was -14.60% per year. And the median was 40.20% per year.

Competitive Comparison of Angelalign Technology's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Angelalign Technology's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Angelalign Technology's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Angelalign Technology's 3-Year EBITDA Growth Rate falls into.

Angelalign Technology 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Angelalign Technology (HKSE:06699) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Angelalign Technology 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Angelalign Technology's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Angelalign Technology (HKSE:06699) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Angelalign Technology Inc (HKSE:06699) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

AGLFF:USA

Address

No. 500 Zhengli Road, 6th Floor - 7th Floor, Building No. 7, KIC Business Center, Yangpu District, Shanghai, CHN

Website

https://www.angelalign.com

Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontics solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review and modify treatment plans.

Executives

Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you
Carecapital Ea, Inc	2201 Interest of corporation controlled by you
Carecapital Management Group Llc	2201 Interest of corporation controlled by you
Carecapital Moonstone Holdings Limited	2201 Interest of corporation controlled by you
Carecapital Dental Holdings Limited	2201 Interest of corporation controlled by you
Feng Dai	2201 Interest of corporation controlled by you
Shore Lead Limited	2201 Interest of corporation controlled by you
Sky Honour Enterprises Limited	2101 Beneficial owner
Li Huamin	2307 Founder of a discretionary trust who can infl
Carecapital Orthotech Limited	2101 Beneficial owner
Chen Kai	2201 Interest of corporation controlled by you
Jovial Day Global Limited	2201 Interest of corporation controlled by you
Vast Luck Global Limited	2101 Beneficial owner
Xing Zheng Quan Qiu Ji Jin Guan Li You Xian Gong Si	2102 Investment manager

Angelalign Technology (HKSE:06699) Headlines

No Headlines